🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

3,061 results for “Bio” Clear

  1. BBP-398 with nivolumab

    BridgeBio Oncology Therapeutics

    Non Small Cell Lung Cancer

    phase 1 small molecule terminated

    1 trial

  2. BBP-671

    BridgeBio Oncology Therapeutics

    Healthy Volunteers

    phase 1 small molecule terminated

    1 trial

  3. BBP-711

    BridgeBio Oncology Therapeutics

    Healthy

    phase 1 small molecule completed

    1 trial

  4. BC-101

    BRIGHT MINDS BIOSCIENCES INC.

    Nasolabial Fold Wrinkles

    phase 1 mab active

    1 trial

  5. BCMA/CD70 CAR-T cells

    Chongqing Precision Biotech Co., Ltd

    Systemic Lupus Erythematosus

    phase 1 mab active

    1 trial

  6. BCMA/CD70-targetd CAR-T

    Chongqing Precision Biotech Co., Ltd

    Juvenile Dermatomyositis (JDM)

    phase 1 mab active

    1 trial

  7. BCT197

    Mereo BioPharma Group plc

    Interaction

    phase 1 small molecule completed

    2 trials

  8. BCX10013

    Biocryst

    Paroxysmal Nocturnal Hemoglobinuria

    phase 1 small molecule completed

    1 trial

  9. BCX17725

    Biocryst

    Netherton Syndrome

    phase 1 small molecule active

    1 trial

  10. BCX4430

    Biocryst

    Filovirus Infections

    phase 1 small molecule completed

    1 trial

  11. BCX7353 and probes

    Biocryst

    Hereditary Angioedema

    phase 1 small molecule completed

    1 trial

  12. BDC-3042

    Bolt Biotherapeutics

    Triple Negative Breast Cancer

    phase 1 small molecule terminated

    1 trial

  13. BF-Amlodipine Tablet 10mg

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy

    phase 1 small molecule completed

    1 trial

  14. BF-Gliclazide Tablet 80mg

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy

    phase 1 small molecule completed

    1 trial

  15. BF-Lisinopril Tablets 20mg

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy

    phase 1 small molecule active

    1 trial

  16. BF-Methyldopa 250mg Tablet

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy

    phase 1 small molecule completed

    1 trial

  17. BF-Metoprolol Tablet 100mg

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy

    phase 1 small molecule active

    1 trial

  18. BGM-2121

    Chongqing Precision Biotech Co., Ltd

    Advanced Solid Tumors

    phase 1 small molecule active

    1 trial

  19. BHV-1300

    Biohaven Bioscience Ireland Limited

    Graves Disease

    phase 1 small molecule active

    1 trial

  20. BICX104

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid-use Disorder

    phase 1 small molecule completed

    1 trial

  21. BICX104 naltrexone implantable pellet

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy Adult Male and Female Volunteers

    phase 1 small molecule active

    1 trial

  22. BIIB115

    Biogen

    Healthy Volunteer

    phase 1 small molecule active

    1 trial

  23. BIO 300 Oral Powder

    United Therapeutics Europe Ltd

    Acute Radiation Syndrome

    phase 1 small molecule completed

    1 trial

  24. BIOPIN-6 Active Implant with Naltrexone

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    phase 1 other completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources